Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ashton

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Pharmacology|August 20, 2002
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malariaUlrika S H Svensson, Hassan Alin, Mats O Karlsson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimensToufigh Gordi, Dinh Xuan Huong, Trinh Ngoc Hai, et al.
Plos Neglected Tropical Diseases|July 12, 2021
Enantiospecific antitrypanosomal in vitro activity of eflornithineMikael Boberg, Monica Cal, Marcel Kaiser, et al.
European Journal of Clinical Pharmacology|March 30, 2006
Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjectsDaniel Röshammar, Trinh Ngoc Hai, Sofia Friberg Hietala, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized DosingJesper Sundell, Marie Wijk, Emile Bienvenu, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 7, 2023
Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation frameworkEmma Eckernäs, Jeroen Koomen, Christopher Timmermann, et al.
Arzneimittel-Forschung|December 24, 2010
Effects of oral administration of synthesized delta-amides of eflornithine in the ratKevin J Helena, David D N'Da, Carl C Johansson, et al.
Bioanalysis|November 12, 2014
A high-throughput LC-MS/MS assay for quantification of artesunate and its metabolite dihydroartemisinin in human plasma and salivaSofia Birgersson, Therese Ericsson, Antje Blank, et al.
European Journal of Clinical Pharmacology|December 7, 2007
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in ZimbabweChristopher Nyakutira, Daniel Röshammar, Emmanuel Chigutsa, et al.
Journal of Travel Medicine|May 9, 2022
Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjectsMita M Thapar, Johan Ursing, Michael Ashton, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|August 20, 2002
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malariaUlrika S H Svensson, Hassan Alin, Mats O Karlsson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimensToufigh Gordi, Dinh Xuan Huong, Trinh Ngoc Hai, et al.
Plos Neglected Tropical Diseases|July 12, 2021
Enantiospecific antitrypanosomal in vitro activity of eflornithineMikael Boberg, Monica Cal, Marcel Kaiser, et al.
European Journal of Clinical Pharmacology|March 30, 2006
Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjectsDaniel Röshammar, Trinh Ngoc Hai, Sofia Friberg Hietala, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized DosingJesper Sundell, Marie Wijk, Emile Bienvenu, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 7, 2023
Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation frameworkEmma Eckernäs, Jeroen Koomen, Christopher Timmermann, et al.
Arzneimittel-Forschung|December 24, 2010
Effects of oral administration of synthesized delta-amides of eflornithine in the ratKevin J Helena, David D N'Da, Carl C Johansson, et al.
Bioanalysis|November 12, 2014
A high-throughput LC-MS/MS assay for quantification of artesunate and its metabolite dihydroartemisinin in human plasma and salivaSofia Birgersson, Therese Ericsson, Antje Blank, et al.
European Journal of Clinical Pharmacology|December 7, 2007
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in ZimbabweChristopher Nyakutira, Daniel Röshammar, Emmanuel Chigutsa, et al.
Journal of Travel Medicine|May 9, 2022
Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjectsMita M Thapar, Johan Ursing, Michael Ashton, et al.
Pageof 7